70 A 20-Year Outcomes' Study of Patients With Immunoglobulin G4-Related Sclerosing Cholangitis: The Mayo Clinic Experience
METHODS: In this retrospective, single center, cohort study, we identified patients who
received a diagnosis of IgG4-SC at Mayo Clinic Rochester from 1999 to 2018. The diagnosis …
received a diagnosis of IgG4-SC at Mayo Clinic Rochester from 1999 to 2018. The diagnosis …
Different manifestations of IgG4 related sclerosing cholangitis: Clinical myths and pearls.
Introduction: IgG4-related sclerosing cholangitis is a rare inflammatory disease that
characterized by elevated serum IgG4 levels, storiform fibrosis pattern of IgG4 positive …
characterized by elevated serum IgG4 levels, storiform fibrosis pattern of IgG4 positive …
Elevated serum and tissue levels of IgG4 in Primary Sclerosing Cholangitis are associated with a worse clinical outcome: 2024
Introduction-IgG4-related cholangitis (IC) is the biliary manifestation of IgG4-related disease,
an increasingly recognised phenomenon with elevated serum and tissue IgG4 incorporated …
an increasingly recognised phenomenon with elevated serum and tissue IgG4 incorporated …
Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification
T Nakazawa, I Naitoh, K Hayashi, F Okumura… - Journal of …, 2012 - Springer
Background IgG4-related sclerosing cholangitis (IgG4-SC) needs to be differentiated from
pancreatic cancer (PCa), primary sclerosing cholangitis (PSC), and cholangiocarcinoma …
pancreatic cancer (PCa), primary sclerosing cholangitis (PSC), and cholangiocarcinoma …
[PDF][PDF] Clinical features of isolated proximal‐type immunoglobulin G4‐related sclerosing cholangitis
髙木由理, タカギユリ - ycu.repo.nii.ac.jp
IgG4 関連硬化性胆管炎 (IgG4-SC) は, ステロイド反応性の良性疾患で, 診断には IgG4
関連硬化性胆管炎臨床診断基準 (岡崎ら, 2012) が用いられ, 胆管像や病理所見から診断がなされ …
関連硬化性胆管炎臨床診断基準 (岡崎ら, 2012) が用いられ, 胆管像や病理所見から診断がなされ …
A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse
X Dong, N Huo, Z Wu, G Wang, H Wang, H Zhao - Medicine, 2018 - journals.lww.com
Interventions: Prednisolone was started from 40 mg daily, tapered gradually, and totally
withdrawn after 22 months of treatment. Outcomes: A new-onset cholangitis was detected 2 …
withdrawn after 22 months of treatment. Outcomes: A new-onset cholangitis was detected 2 …
Nationwide survey for primary sclerosing cholangitis and IgG 4‐related sclerosing cholangitis in J apan
A Tanaka, S Tazuma, K Okazaki… - Journal of Hepato …, 2014 - Wiley Online Library
Background We previously conducted nationwide surveys for primary sclerosing cholangitis
(PSC) in J apan, and demonstrated several characteristic features of J apanese PSC …
(PSC) in J apan, and demonstrated several characteristic features of J apanese PSC …
A6 HIGH SERUM IGG4 IS ASSOCIATED WITH A SHORTER TIME TO CIRRHOSIS DEVELOPMENT, HEPATIC DECOMPENSATION, AND LIVER …
L Du, AJ Montano-Loza, F Peerani - Journal of the Canadian …, 2018 - academic.oup.com
Background Primary sclerosing cholangitis (PSC) is an immune-mediated biliary disorder of
unknown etiology for which there is no effective treatment. Eventually all PSC patients …
unknown etiology for which there is no effective treatment. Eventually all PSC patients …
Diagnostic Criteria
H Ohara, I Naitoh, K Hayashi, K Miyabe… - IgG4-Related Sclerosing …, 2019 - Springer
As IgG4-related sclerosing cholangitis (IgG4-SC) exhibits various cholangiographic features
similar to those of primary sclerosing cholangitis (PSC), pancreatic cancer, and …
similar to those of primary sclerosing cholangitis (PSC), pancreatic cancer, and …